Simplex Trading’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $52.5K | Sell |
2,400
-42,400
| -95% | -$882K | ﹤0.01% | 6263 |
|
|
2026
Q1 | $1.05M | Sell |
44,800
-14,300
| -24% | -$311K | ﹤0.01% | 2454 |
|
|
2025
Q4 | $1.24M | Sell |
59,100
-11,000
| -16% | -$192K | ﹤0.01% | 2419 |
|
|
2025
Q3 | $1.08M | Buy |
70,100
+35,700
| +104% | +$467K | ﹤0.01% | 2974 |
|
|
2025
Q2 | $322K | Buy |
34,400
+12,400
| +56% | +$136K | ﹤0.01% | 3988 |
|
|
2025
Q1 | $270K | Buy |
22,000
+21,600
| +5,400% | +$305K | ﹤0.01% | 4018 |
|
|
2024
Q4 | $5K | Sell |
400
-8,700
| -96% | -$149K | ﹤0.01% | 7656 |
|
|
2024
Q3 | $175K | Buy |
9,100
+2,000
| +28% | +$41.3K | ﹤0.01% | 4652 |
|
|
2024
Q2 | $145K | Sell |
7,100
-9,300
| -57% | -$195K | ﹤0.01% | 4971 |
|
|
2024
Q1 | $390K | Sell |
16,400
-131,800
| -89% | -$2.94M | ﹤0.01% | 4096 |
|
|
2023
Q4 | $3.2M | Buy |
148,200
+36,900
| +33% | +$567K | ﹤0.01% | 1940 |
|
|
2023
Q3 | $1.62M | Buy |
+111,300
| New | +$2.11M | ﹤0.01% | 2263 |
|
|
2023
Q1 | – | Sell |
-100
| Closed | -$2K | – | 10048 |
|
|
2022
Q4 | $2K | Hold |
100
| – | – | ﹤0.01% | 8653 |
|
|
2022
Q3 | $2K | Buy |
+100
| New | +$2.24K | ﹤0.01% | 9359 |
|
|
2022
Q2 | – | Sell |
-1,100
| Closed | -$19K | – | 11010 |
|
|
2022
Q1 | $19K | Buy |
1,100
+900
| +450% | +$15.2K | ﹤0.01% | 8313 |
|
|
2021
Q4 | $4K | Sell |
200
-100
| -33% | -$1.85K | ﹤0.01% | 9710 |
|
|
2021
Q3 | $5K | Hold |
300
| – | – | ﹤0.01% | 9292 |
|
|
2021
Q2 | $5K | Buy |
300
+294
| +4,900% | +$5.38K | ﹤0.01% | 9478 |
|
|
2021
Q1 | $13K | Sell |
6
-6
| -50% | -$136 | ﹤0.01% | 7763 |
|
|
2020
Q4 | $26K | Buy |
+12
| New | +$249 | ﹤0.01% | 6797 |
|
|
2020
Q3 | – | Sell |
-61
| Closed | -$90K | – | 8453 |
|
|
2020
Q2 | $90K | Buy |
61
+19
| +45% | +$289 | ﹤0.01% | 4899 |
|
|
2020
Q1 | $46K | Sell |
42
-19
| -31% | -$178 | ﹤0.01% | 5222 |
|
|
2019
Q4 | $53K | Buy |
61
+53
| +663% | +$389 | ﹤0.01% | 5132 |
|
|
2019
Q3 | $5K | Sell |
8
-19
| -70% | -$173 | ﹤0.01% | 6627 |
|
|
2019
Q2 | $25K | Sell |
27
-25
| -48% | -$182 | ﹤0.01% | 5443 |
|
|
2019
Q1 | $27K | Buy |
52
+28
| +117% | +$160 | ﹤0.01% | 5501 |
|
|
2018
Q4 | $10K | Sell |
24
-16
| -40% | -$88 | ﹤0.01% | 5858 |
|
|
2018
Q3 | $32K | Buy |
40
+38
| +1,900% | +$271 | ﹤0.01% | 5592 |
|
|
2018
Q2 | $1K | Buy |
+2
| New | +$20 | ﹤0.01% | 7192 |
|
Other funds holding SNDX
KCM
DM
EP
HRCM
Simplex Trading's SNDX Position: Q2 2026 in Review
Simplex Trading reduced its Syndax Pharmaceuticals (SNDX) stake by 86% in Q2 2026, selling an estimated $371K and leaving 2,991 shares worth $65.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6022.
Simplex Trading first reported a position in SNDX in Q2 2018 and has held it in 21 quarters since. The position peaked at $1.38M in Q4 2023. 243 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.
- Simplex Trading held 2,991 shares of Syndax Pharmaceuticals worth $65.4K as of Q2 2026.
- Simplex Trading sold 17,834 Syndax Pharmaceuticals shares in Q2 2026, an estimated $371K.
- Syndax Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #6022 holding.
- Simplex Trading first reported a position in Syndax Pharmaceuticals in Q2 2018 and has held it in 21 quarters since.
- Simplex Trading's Syndax Pharmaceuticals position peaked at $1.38M in Q4 2023.
- 243 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.